Rafael (NYSE:RFL) Trading Up 4.6% – What’s Next?

Rafael Holdings, Inc. (NYSE:RFL) shares rose 4.6% during mid-day trading on Tuesday . The company traded as high as $3.49 and last traded at $3.3050. 472,465 shares traded hands during trading, an increase of 50% from the average daily volume of 316,004 shares. The stock had previously closed at $3.16.

Analyst Ratings Changes

Separately, Weiss Ratings raised shares of Rafael from a “sell (e+)” rating to a “sell (d-)” rating in a report on Thursday, May 28th. One analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the company has an average rating of “Sell”.

Rafael Stock Performance

The stock has a 50 day simple moving average of $1.73 and a two-hundred day simple moving average of $1.43. The firm has a market cap of $171.86 million, a PE ratio of -4.86 and a beta of 0.54.

Rafael (NYSE:RFL) last issued its quarterly earnings data on Thursday, June 11th. The company reported ($0.08) earnings per share (EPS) for the quarter. The company had revenue of $0.18 million during the quarter. Rafael had a negative net margin of 3,321.74% and a negative return on equity of 41.27%.

Institutional Inflows and Outflows

A number of large investors have recently bought and sold shares of the stock. Marshall Wace LLP acquired a new stake in shares of Rafael during the 2nd quarter worth approximately $50,000. Citadel Advisors LLC lifted its stake in shares of Rafael by 132.3% in the 3rd quarter. Citadel Advisors LLC now owns 72,584 shares of the company’s stock valued at $99,000 after purchasing an additional 41,335 shares during the period. Renaissance Technologies LLC lifted its stake in shares of Rafael by 59.1% in the 1st quarter. Renaissance Technologies LLC now owns 89,138 shares of the company’s stock valued at $111,000 after purchasing an additional 33,111 shares during the period. Cable Car Capital LP purchased a new stake in Rafael during the second quarter worth $173,000. Finally, Geode Capital Management LLC boosted its holdings in Rafael by 25.4% during the fourth quarter. Geode Capital Management LLC now owns 445,866 shares of the company’s stock worth $526,000 after buying an additional 90,417 shares in the last quarter. 11.30% of the stock is owned by institutional investors and hedge funds.

Rafael Company Profile

Rafael Holdings, Inc primarily engages in holding interests in clinical and early-stage pharmaceutical companies, and commercial real estate assets in the United States and Israel. It operates in two segments, Healthcare and Real Estate. The company engages in the development and commercialization of therapies that exploit the metabolic differences between normal cells and cancer cells. Its lead drug candidate is CPI-613 (devimistat), currently under Phase III clinical study for the treatment of metastatic pancreatic cancer and acute myeloid leukemia.